Canada Vows to Defend its Drug Supply Against Florida Importation Plan
upstart writes:
Canada adds that importing its drugs will not solve America's drug pricing problems:
Canada issued a warning Monday that it stands ready to defend its prescription drug supply from US importation plans-and also said the plans wouldn't work for the US, anyway. "Bulk importation will not provide an effective solution to the problem of high drug prices in the US," Health Canada said in a statement.
The defensive stance comes just days after the US Food and Drug Administration granted Florida authorization to directly import cheaper prescription drugs from Canada in an effort to help drag down America's uniquely stratospheric drug pricing. Florida is the first state to win such an authorization, and Florida Governor Ron DeSantis celebrated it, claiming the drug imports will save the state "up to $180 million in the first year alone." There are caveats, though. Before Florida can import any drugs, it must complete several obligations, including submitting to the FDA additional drug-specific information, testing the drugs for authenticity and FDA compliance, and relabeling them in accordance with FDA labeling.
The FDA authorized the importation program in accordance with section 804 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The move stems from President Biden's "Executive Order on Promoting Competition in the American Economy," which directed the FDA to help develop such programs.
[...] Proponents of the program in the US say that importing cheaper drugs from abroad could help lower US drug prices by offering more competition on the market. Canada, like other countries, has lower drug prices than the US, partly because the country's national health system negotiates prices for prescription drugs. The US government only began negotiating prices last year-and is currently being sued by several pharmaceutical companies over the move.
But Canada, which has a population around nine times smaller than the US, has been staunchly opposed to the US importing its drugs. It has repeatedly said that diverting medicines to the US could lead to drug shortages in Canada, make existing shortages worse, and/or cause price spikes.
[...] Drug makers in the US also intend to fight the plans. Stephen Ubl, CEO of the powerful trade group PhRMA-Pharmaceutical Research and Manufacturers of America-said in a statement that the group is "deeply concerned with the FDA's reckless decision to approve Florida's state importation plan" and claimed importation "poses a serious danger to public health." Ubl concluded that "PhRMA is considering all options for preventing this policy from harming patients."
Read more of this story at SoylentNews.